Pauline Verdijk

2.3k citations

22 papers · 1.9k indexed · 1 hit paper · h-index 18

Co-authors: Carl G. Figdor I. Jolanda M. de Vries Cornelis J.A. Punt Gosse J. Adema W. Joost Lesterhuis Wim J.G. Oyen Otto C. Boerman Johannes J. Bonenkamp
Topics: Immunotherapy and Immune Responses (9 papers)T-cell and B-cell Immunology (6 papers)Viral Infections and Immunology Research (5 papers)
Cited by: Immunology Oncology Biomaterials
Journals: The Journal of Experimental Medicine Blood Nature Biotechnology
Partner nations: Netherlands United States Switzerland

In The Last Decade

Pauline Verdijk

22 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

2005 666 citations I. Jolanda M. de Vries, W. Joost Lesterhuis et al. profile →

Peers

Countries citing papers authored by Pauline Verdijk

Since Specialization

Citations

This map shows the geographic impact of Pauline Verdijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pauline Verdijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pauline Verdijk more than expected).

Fields of papers citing papers by Pauline Verdijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pauline Verdijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pauline Verdijk. The network helps show where Pauline Verdijk may publish in the future.

Co-authorship network of co-authors of Pauline Verdijk

This figure shows the co-authorship network connecting the top 25 collaborators of Pauline Verdijk. A scholar is included among the top collaborators of Pauline Verdijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pauline Verdijk. Pauline Verdijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial 2020 ·Vaccine ·Pauline Verdijk,(unknown),Emilie M.J. van Brummelen,Rienk E. Jeeninga,Cornelis A. M. de Haan,Meta Roestenberg,Jacobus Burggraaf,Ingrid M. C. Kamerling	18
2	Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season 2019 ·Human Vaccines & Immunotherapeutics ·(unknown),Pauline Verdijk,Emilie M.J. van Brummelen,Rienk E. Jeeninga,Meta Roestenberg,Jacobus Burggraaf,Ingrid M. C. Kamerling	3
3	Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial 2015 ·Human Vaccines & Immunotherapeutics ·(unknown),Pauline Verdijk,(unknown),Elly van Riet,Tjeert T. Mensinga,Willem Luytjes	8
4	Preclinical evaluation of aHaemophilus influenzaetype b conjugate vaccine process intended for technology transfer 2014 ·Human Vaccines & Immunotherapeutics ·(unknown),Pauline Verdijk,(unknown)	1
5	Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants 2014 ·Vaccine ·Pauline Verdijk,Nynke Y. Rots,Monique G.C.T. van Oijen,William C. Weldon,M. Steven Oberste,Hiromasa Okayasu,Roland W. Sutter,Wilfried A.M. Bakker	32
6	Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: A phase I Trial in healthy adults in Cuba 2014 ·Vaccine ·Sonia Resik,Alina Tejeda,Magilé Fonseca,(unknown),Manuel Dı́az,(unknown),(unknown),Hiromasa Okayasu,Anthony Burton,Wilfried A.M. Bakker,Pauline Verdijk,Roland W. Sutter	17
7	Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells 2013 ·Clinical Cancer Research ·Erik H.J.G. Aarntzen,Mangala Srinivas,F. Bonetto,Luis J. Cruz,Pauline Verdijk,Gerty Schreibelt,(unknown),W. Joost Lesterhuis,(unknown),(unknown),Gosse J. Adema,Arend Heerschap,Carl G. Figdor,Wim J.G. Oyen,I. Jolanda M. de Vries	49
8	Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: A phase I trial in healthy adults 2013 ·Vaccine ·Pauline Verdijk,Nynke Y. Rots,Monique G.C.T. van Oijen,M. Steven Oberste,Claire J. P. Boog,Hiromasa Okayasu,Roland W. Sutter,Wilfried A.M. Bakker	29
9	Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults 2013 ·Vaccine ·Darius Soonawala,Pauline Verdijk,Alienke J. Wijmenga‐Monsuur,Claire J. P. Boog,(unknown),Leo G. Visser,Nynke Y. Rots	45
10	Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains 2011 ·Expert Review of Vaccines ·Pauline Verdijk,Nynke Y. Rots,Wilfried A.M. Bakker	22
11	Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients 2009 ·Clinical Cancer Research ·Pauline Verdijk,Erik H.J.G. Aarntzen,W. Joost Lesterhuis,(unknown),(unknown),Michelle M. van Rossum,S P Strijk,(unknown),Johannes J. Bonenkamp,Joannes F.M. Jacobs,Willeke A.M. Blokx,(unknown),Irma Joosten,Otto C. Boerman,Wim J.G. Oyen,Gosse J. Adema,Cornelis J.A. Punt,Carl G. Figdor,I. Jolanda M. de Vries	168
12	In situ Expression of Tumor Antigens by Messenger RNA–Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients 2009 ·Cancer Research ·Danita H. Schuurhuis,Pauline Verdijk,Gerty Schreibelt,Erik H.J.G. Aarntzen,Nicole M. Scharenborg,Annemiek de Boer,Mandy W.M.M. van de Rakt,(unknown),Marie‐Jeanne P. Gerritsen,(unknown),Johannes J. Bonenkamp,Willeke A.M. Blokx,J. Han van Krieken,Otto C. Boerman,Wim J.G. Oyen,Cornelis J.A. Punt,Carl G. Figdor,Gosse J. Adema,I. Jolanda M. de Vries	46
13	Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration 2008 ·Cancer Immunology Immunotherapy ·(unknown),Erik H.J.G. Aarntzen,Pauline Verdijk,Joannes F.M. Jacobs,Danita H. Schuurhuis,Daniel Benítez‐Ribas,Gerty Schreibelt,Mandy W.M.M. van de Rakt,Nicole M. Scharenborg,Annemiek de Boer,Matthijs Kramer,Carl G. Figdor,Cornelis J.A. Punt,Gosse J. Adema,I. Jolanda M. de Vries	122
14	Maximizing dendritic cell migration in cancer immunotherapy 2008 ·Expert Opinion on Biological Therapy ·Pauline Verdijk,Erik H.J.G. Aarntzen,Cornelis J. A. Punt,I. Jolanda M. de Vries,Carl G. Figdor	50
15	Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines 2006 ·International Journal of Cancer ·Pauline Verdijk,Tom W. J. Scheenen,W. Joost Lesterhuis,Giulio Gambarota,Andor Veltien,Piotr Walczak,Nicole M. Scharenborg,Jeff W. M. Bulte,Cornelis J.A. Punt,Arend Heerschap,Carl G. Figdor,I. Jolanda M. de Vries	75
16	Synthesis and structure–activity relationship of 3-phenyl-3H-quinazolin-4-one derivatives as CXCR3 chemokine receptor antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Pauline Verdijk,Dennis Verzijl,Henk Timmerman,(unknown),Cornelis P. Tensen,Martine J. Smit,Iwan J. P. de Esch,Rob Leurs	27
17	A Lack of Birbeck Granules in Langerhans Cells Is Associated with a Naturally Occurring Point Mutation in the Human Langerin Gene 2005 ·Journal of Investigative Dermatology ·Pauline Verdijk,Remco Dijkman,Elsemieke I. Plasmeijer,Aat A. Mulder,Willem H. Zoutman,A. Mieke Mommaas,Cornelis P. Tensen	42
18	CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C–dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase 2003 ·Blood ·Martine J. Smit,Pauline Verdijk,(unknown),Marjon Navis,Paul J. Hensbergen,Rob Leurs,Cornelis P. Tensen	139
19	Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane 2003 ·European Journal of Immunology ·Pauline Verdijk,Peter A. van Veelen,Arnoud H. de Ru,Paul J. Hensbergen,Kensaku Mizuno,Henk K. Koerten,Frits Koning,Cornelis P. Tensen,A. Mieke Mommaas	64
20	Efficient Identification of Novel Hla-A0201–Presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen Prame by Proteasome-Mediated Digestion Analysis 2001 ·The Journal of Experimental Medicine* ·Jan H. Kessler,N. J. C. M. Beekman,(unknown),Pauline Verdijk,Peter A. van Veelen,(unknown),(unknown),George J.A. ten Bosch,Michel G.D. Kester,Alice J.A.M. Sijts,Jan W. Drijfhout,Ferry Ossendorp,Rienk Offringa,Cornelis J.M. Melief	217

About Pauline Verdijk

Pauline Verdijk is a scholar working on Immunology, Immunology and Allergy and Infectious Diseases, having authored 22 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), T-cell and B-cell Immunology (6 papers) and Viral Infections and Immunology Research (5 papers). The work is most often cited by research in Immunology (1.0k citations), Oncology (545 citations) and Biomaterials (204 citations). Pauline Verdijk has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Carl G. Figdor, I. Jolanda M. de Vries, Cornelis J.A. Punt, Gosse J. Adema, W. Joost Lesterhuis, Wim J.G. Oyen, Otto C. Boerman, Johannes J. Bonenkamp, Arend Heerschap and Tom W. J. Scheenen. Their work appears in journals such as The Journal of Experimental Medicine, Blood and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact